{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T05:29:49Z","timestamp":1793770189827,"version":"4.6.1"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T00:00:00Z","timestamp":1783728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T00:00:00Z","timestamp":1787011200000},"content-version":"vor","delay-in-days":38,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["52373287"],"award-info":[{"award-number":["52373287"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-026-75493-9","type":"journal-article","created":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T02:22:46Z","timestamp":1783736566000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Molecular imaging-guided discovery of a potent natural FAP\u03b1 inhibitor for liver fibrosis therapy"],"prefix":"10.1038","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0999-8300","authenticated-orcid":false,"given":"Wenze","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiwei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaoran","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaiyu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiying","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangyi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boyang","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengguo","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haijun","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1076-8959","authenticated-orcid":false,"given":"Xianchuang","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1018-4694","authenticated-orcid":false,"given":"Jiangwei","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,11]]},"reference":[{"key":"75493_CR1","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/S2468-1253(23)00275-3","volume":"9","author":"JA Thomas","year":"2024","unstructured":"Thomas, J. A., Kendall, B. J., El-Serag, H. B., Thrift, A. P. & Macdonald, G. A. Hepatocellular and extrahepatic cancer risk in people with non-alcoholic fatty liver disease. Lancet Gastroenterol. Hepatol. 9, 159\u2013169 (2024).","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"75493_CR2","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/s41392-024-02072-z","volume":"10","author":"C Gan","year":"2025","unstructured":"Gan, C. et al. Liver diseases: epidemiology, causes, trends and predictions. Signal Transduct. Target. Ther. 10, 33 (2025).","journal-title":"Signal Transduct. Target. Ther."},{"key":"75493_CR3","doi-asserted-by":"publisher","first-page":"909455","DOI":"10.3389\/fpubh.2022.909455","volume":"10","author":"F Ye","year":"2022","unstructured":"Ye, F. et al. The burden of liver cirrhosis in mortality: results from the Global Burden of Disease Study. Front. Public Health 10, 909455 (2022).","journal-title":"Front. Public Health"},{"key":"75493_CR4","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.jhep.2018.09.014","volume":"70","author":"SK Asrani","year":"2019","unstructured":"Asrani, S. K., Devarbhavi, H., Eaton, J. & Kamath, P. S. Burden of liver diseases in the world. J. Hepatol. 70, 151\u2013171 (2019).","journal-title":"J. Hepatol."},{"key":"75493_CR5","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1016\/S0140-6736(12)61425-1","volume":"381","author":"P Marcellin","year":"2012","unstructured":"Marcellin, P. et al. Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study. Lancet 381, 468\u2013475 (2012).","journal-title":"Lancet"},{"key":"75493_CR6","doi-asserted-by":"publisher","first-page":"755","DOI":"10.4254\/wjh.v15.i6.755","volume":"15","author":"C Zhang","year":"2023","unstructured":"Zhang, C., Liu, S. & Yang, M. Treatment of liver fibrosis: past, current, and future. World J. Hepatol. 15, 755\u2013774 (2023).","journal-title":"World J. Hepatol."},{"key":"75493_CR7","doi-asserted-by":"crossref","first-page":"609A","DOI":"10.1002\/hep.22643","volume":"48","author":"TT Chang","year":"2008","unstructured":"Chang, T. T. et al. Long-term entecavir therapy results in the reversal of fibrosis\/cirrhosis and continued histological improvement in patients with chronic hepatitis B. Hepatology 48, 609A\u2013706A (2008).","journal-title":"Hepatology"},{"key":"75493_CR8","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1053\/j.gastro.2015.04.005","volume":"149","author":"E Vilar-Gomez","year":"2015","unstructured":"Vilar-Gomez, E. et al. Weight loss through lifestyle modification significantly reduces features of nonalcoholic steatohepatitis. Gastroenterology 149, 367\u2013378 (2015).","journal-title":"Gastroenterology"},{"key":"75493_CR9","doi-asserted-by":"crossref","unstructured":"Hu, X. et al. Molecular imaging probes for early detection and staging of liver fibrosis. Chem. Biomed. Imaging 3, 702\u2013714 (2025).","DOI":"10.1021\/cbmi.5c00055"},{"key":"75493_CR10","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1038\/s41575-024-00909-0","volume":"21","author":"K Ray","year":"2024","unstructured":"Ray, K. Resmetirom proves positive for NASH with liver fibrosis. Nat. Rev. Gastroenterol. Hepatol. 21, 218 (2024).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"75493_CR11","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1002\/hep.23754","volume":"52","author":"A Dech\u00eane","year":"2010","unstructured":"Dech\u00eane, A. et al. Acute liver failure is associated with elevated liver stiffness and hepatic stellate cell activation. Hepatology 52, 1008\u20131016 (2010).","journal-title":"Hepatology"},{"key":"75493_CR12","first-page":"19","volume":"132","author":"M Qi","year":"2023","unstructured":"Qi, M. et al. Targeting FAP\u03b1-expressing hepatic stellate cells overcomes resistance to antiangiogenics in colorectal cancer liver metastasis models. J. Clin. Investig. 132, 19 (2023).","journal-title":"J. Clin. Investig."},{"key":"75493_CR13","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.addr.2017.05.007","volume":"121","author":"T Higashi","year":"2017","unstructured":"Higashi, T., Friedman, S. L. & Hoshida, Y. Hepatic stellate cells as key target in liver fibrosis. Adv. Drug Deliv. Rev. 121, 27\u201342 (2017).","journal-title":"Adv. Drug Deliv. Rev."},{"key":"75493_CR14","doi-asserted-by":"publisher","first-page":"1768","DOI":"10.1002\/hep.510290631","volume":"29","author":"MT Levy","year":"1999","unstructured":"Levy, M. T. et al. Fibroblast activation protein: a cell surface dipeptidyl peptidase and gelatinase expressed by stellate cells at the tissue remodelling interface in human cirrhosis. Hepatology 29, 1768\u20131778 (1999).","journal-title":"Hepatology"},{"key":"75493_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-52308-3","volume":"15","author":"J Gao","year":"2024","unstructured":"Gao, J. et al. A FAP\u03b1-activated MRI nanoprobe for precise grading diagnosis of clinical liver fibrosis. Nat. Commun. 15, 8036 (2024).","journal-title":"Nat. Commun."},{"key":"75493_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2741\/4706","volume":"24","author":"MD Gorrell","year":"2019","unstructured":"Gorrell, M. D. Fibroblast activation protein in liver fibrosis. Front. Biosci. 24, 1\u201317 (2019).","journal-title":"Front. Biosci."},{"key":"75493_CR17","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1021\/acssensors.2c00126","volume":"7","author":"SY Liu","year":"2022","unstructured":"Liu, S. Y. et al. Ultrasensitive fibroblast activation protein-\u03b1-activated fluorogenic probe enables selective imaging and killing of melanoma in vivo. ACS Sens. 7, 1837\u20131846 (2022).","journal-title":"ACS Sens."},{"key":"75493_CR18","doi-asserted-by":"publisher","first-page":"2211485","DOI":"10.1002\/adma.202211485","volume":"35","author":"H Zhou","year":"2023","unstructured":"Zhou, H. et al. A tumor-microenvironment-activatable molecular pro-theranostic agent for photodynamic and immunotherapy of cancer. Adv. Mater. 35, 2211485 (2023).","journal-title":"Adv. Mater."},{"key":"75493_CR19","doi-asserted-by":"publisher","DOI":"10.1002\/anie.202512588","volume":"64","author":"Y Feng","year":"2025","unstructured":"Feng, Y. et al. A general strategy to develop highly sensitive fap\u03b1 fluorescent probes for invasive cancer detection. Angew. Chem. Int. Ed. 64, e202512588 (2025).","journal-title":"Angew. Chem. Int. Ed."},{"key":"75493_CR20","doi-asserted-by":"publisher","first-page":"7996","DOI":"10.1021\/acs.analchem.2c01048","volume":"94","author":"W Li","year":"2022","unstructured":"Li, W. et al. Activatable fluorescent-photoacoustic integrated probes with deep tissue penetration for pathological diagnosis and therapeutic evaluation of acute inflammation in mice. Anal. Chem. 94, 7996\u20138004 (2022).","journal-title":"Anal. Chem."},{"key":"75493_CR21","doi-asserted-by":"publisher","first-page":"2300023","DOI":"10.1002\/adfm.202300023","volume":"33","author":"Q Shen","year":"2023","unstructured":"Shen, Q. et al. Stimuli-responsive organic near-infrared photoacoustic probes. Adv. Funct. Mater. 33, 2300023 (2023).","journal-title":"Adv. Funct. Mater."},{"key":"75493_CR22","doi-asserted-by":"publisher","first-page":"11686","DOI":"10.1021\/jacs.8b05514","volume":"140","author":"EY Zhou","year":"2018","unstructured":"Zhou, E. Y. et al. Near-infrared photoactivatable nitric oxide donors with integrated photoacoustic monitoring. J. Am. Chem. Soc. 140, 11686\u201311697 (2018).","journal-title":"J. Am. Chem. Soc."},{"key":"75493_CR23","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.2967\/jnumed.125.269572","volume":"66","author":"H Lanzafame","year":"2025","unstructured":"Lanzafame, H. et al. 90Y-FAPI-46 theranostics leads to near-complete metabolic response in 3 patients with solitary fibrous tumors. J. Nucl. Med. 66, 1378\u20131384 (2025).","journal-title":"J. Nucl. Med."},{"key":"75493_CR24","doi-asserted-by":"publisher","first-page":"2844","DOI":"10.1007\/s00259-022-05706-y","volume":"49","author":"M Li","year":"2022","unstructured":"Li, M. et al. Clinical summary of fibroblast activation protein inhibitor-based radiopharmaceuticals: cancer and beyond. Eur. J. Nucl. Med. Mol. Imaging 49, 2844\u20132868 (2022).","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"75493_CR25","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1038\/s41392-024-01853-w","volume":"9","author":"L Zhao","year":"2024","unstructured":"Zhao, L. et al. Antitumor efficacy and potential mechanism of FAP-targeted radioligand therapy combined with immune checkpoint blockade. Signal Transduct. Target. Ther. 9, 142 (2024).","journal-title":"Signal Transduct. Target. Ther."},{"key":"75493_CR26","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1038\/s41586-019-1263-7","volume":"570","author":"AP Croft","year":"2019","unstructured":"Croft, A. P. et al. Distinct fibroblast subsets drive inflammation and damage in arthritis. Nature 570, 246\u2013251 (2019).","journal-title":"Nature"},{"key":"75493_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-29186-8","volume":"13","author":"J Lee","year":"2022","unstructured":"Lee, J. et al. Fibroblast activation protein-activated antifibrotic peptide delivery attenuates fibrosis in mouse models of liver fibrosis. Nat. Commun. 13, 1516 (2022).","journal-title":"Nat. Commun."},{"key":"75493_CR28","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1016\/j.jcmgh.2022.12.005","volume":"15","author":"AT Yang","year":"2023","unstructured":"Yang, A. T. et al. Fibroblast activation protein activates macrophages and promotes parenchymal liver inflammation and fibrosis. Cell. Mol. Gastroenterol. Hepatol. 15, 841\u2013867 (2023).","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"key":"75493_CR29","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1016\/j.gendis.2021.12.011","volume":"10","author":"Y Zhang","year":"2023","unstructured":"Zhang, Y. et al. Friend or foe for obesity: How hepatokines remodel adipose tissues and translational perspective. Genes Dis. 10, 825\u2013847 (2023).","journal-title":"Genes Dis."},{"key":"75493_CR30","doi-asserted-by":"publisher","first-page":"1135384","DOI":"10.3389\/fimmu.2023.1135384","volume":"14","author":"Z Wang","year":"2023","unstructured":"Wang, Z. et al. Role and mechanism of fibroblast-activated protein-\u03b1 expression on the surface of fibroblast-like synoviocytes in rheumatoid arthritis. Front. Immunol. 14, 1135384 (2023).","journal-title":"Front. Immunol."},{"key":"75493_CR31","doi-asserted-by":"publisher","first-page":"S641","DOI":"10.1016\/S0168-8278(25)01714-3","volume":"82","author":"V Azzu","year":"2025","unstructured":"Azzu, V. et al. SAT-462 First-in-human single and multiple ascending dose study of AZD2389, a potent inhibitor of fibroblast activation protein, in healthy participants to evaluate safety, tolerability, pharmacokinetics and target engagement. J. Hepatol. 82, S641\u2013S642 (2025).","journal-title":"J. Hepatol."},{"key":"75493_CR32","doi-asserted-by":"publisher","first-page":"18860","DOI":"10.1002\/anie.202105905","volume":"60","author":"SH Gardner","year":"2021","unstructured":"Gardner, S. H. et al. A General approach to convert hemicyanine dyes into highly optimized photoacoustic scaffolds for analyte sensing. Angew. Chem. Int. Ed. 60, 18860\u201318866 (2021).","journal-title":"Angew. Chem. Int. Ed."},{"key":"75493_CR33","doi-asserted-by":"publisher","first-page":"6501","DOI":"10.1021\/acs.analchem.1c00413","volume":"93","author":"A Fu","year":"2021","unstructured":"Fu, A. et al. A novel chemiluminescence probe for sensitive detection of fibroblast activation protein-alpha in vitro and in living systems. Anal. Chem. 93, 6501\u20136507 (2021).","journal-title":"Anal. Chem."},{"key":"75493_CR34","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1002\/ange.201710727","volume":"130","author":"Q Miao","year":"2018","unstructured":"Miao, Q. et al. Near-infrared fluorescent molecular probe for sensitive imaging of keloid. Angew. Chem. Int. Ed. 130, 1270\u20131274 (2018).","journal-title":"Angew. Chem. Int. Ed."},{"key":"75493_CR35","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.2967\/jnumed.118.210435","volume":"59","author":"A Loktev","year":"2018","unstructured":"Loktev, A. et al. A tumor-imaging method targeting cancer-associated fibroblasts. J. Nucl. Med. 59, 1423\u20131429 (2018).","journal-title":"J. Nucl. Med."},{"key":"75493_CR36","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1038\/nrgastro.2017.38","volume":"14","author":"T Tsuchida","year":"2017","unstructured":"Tsuchida, T. & Friedman, S. L. Mechanisms of hepatic stellate cell activation. Nat. Rev. Gastroenterol. Hepatol. 14, 397\u2013411 (2017).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"75493_CR37","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1038\/s41589-024-01704-3","volume":"21","author":"L Gan","year":"2025","unstructured":"Gan, L. et al. A natural small molecule alleviates liver fibrosis by targeting apolipoprotein L2. Nat. Chem. Biol. 21, 80\u201390 (2025).","journal-title":"Nat. Chem. Biol."},{"key":"75493_CR38","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/j.jhep.2019.05.029","volume":"71","author":"Y Liu","year":"2019","unstructured":"Liu, Y. et al. Activation of YAP attenuates hepatic damage and fibrosis in liver ischemia-reperfusion injury. J. Hepatol. 71, 719\u2013730 (2019).","journal-title":"J. Hepatol."},{"key":"75493_CR39","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1038\/s41588-024-01819-2","volume":"56","author":"L Franz\u00e9n","year":"2024","unstructured":"Franz\u00e9n, L. et al. Mapping spatially resolved transcriptomes in human and mouse pulmonary fibrosis. Nat. Genet. 56, 1725\u20131736 (2024).","journal-title":"Nat. Genet."},{"key":"75493_CR40","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.1136\/gutjnl-2016-313392","volume":"67","author":"D Xiang","year":"2018","unstructured":"Xiang, D. et al. The HLF\/IL-6\/STAT3 feedforward circuit drives hepatic stellate cell activation to promote liver fibrosis. Gut 67, 1704\u20131715 (2018).","journal-title":"Gut"},{"key":"75493_CR41","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1038\/nchem.2479","volume":"8","author":"T Rodrigues","year":"2016","unstructured":"Rodrigues, T., Reker, D., Schneider, P. & Schneider, G. Counting on natural products for drug design. Nat. Chem. 8, 531\u2013541 (2016).","journal-title":"Nat. Chem."},{"key":"75493_CR42","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1021\/acs.jnatprod.9b01285","volume":"83","author":"DJ Newman","year":"2020","unstructured":"Newman, D. J. & Cragg, G. M. Natural products as sources of new drugs over the nearly four decades from 01\/1981 to 09\/2019. J. Nat. Prod. 83, 770\u2013803 (2020).","journal-title":"J. Nat. Prod."},{"key":"75493_CR43","first-page":"1153","volume":"23","author":"J Zhang","year":"2025","unstructured":"Zhang, J. et al. Research progress on new techniques and methods for identifying active ingredients in traditional Chinese medicine. Chin. J. Nat. Med. 23, 1153\u20131170 (2025).","journal-title":"Chin. J. Nat. Med."},{"key":"75493_CR44","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202311397","volume":"36","author":"W Zhang","year":"2024","unstructured":"Zhang, W. et al. Discovering a new drug against acute kidney injury by using a tailored photoacoustic imaging probe. Adv. Mater. 36, e2311397 (2024).","journal-title":"Adv. Mater."},{"key":"75493_CR45","doi-asserted-by":"publisher","first-page":"2303926","DOI":"10.1002\/advs.202303926","volume":"10","author":"H Gao","year":"2023","unstructured":"Gao, H. et al. Illumination of hydroxyl radical in kidney injury and high-throughput screening of natural protectants using a fluorescent\/photoacoustic probe. Adv. Sci. 10, 2303926 (2023).","journal-title":"Adv. Sci."},{"key":"75493_CR46","unstructured":"Zhou, X. Master\u2019s thesis (Guangdong Pharmaceutical University, 2017)."},{"key":"75493_CR47","first-page":"810","volume":"22","author":"C Deng","year":"2020","unstructured":"Deng, C. et al. Research progress on the chemical constituents and pharmacological activities of Caesalpinia sappan. Chin. J. Mod. Tradit. Chin. Med. 22, 810\u2013826 (2020).","journal-title":"Chin. J. Mod. Tradit. Chin. Med."},{"key":"75493_CR48","doi-asserted-by":"publisher","first-page":"140409","DOI":"10.1016\/j.bbapap.2020.140409","volume":"1868","author":"A \u0160imkov\u00e1","year":"2020","unstructured":"\u0160imkov\u00e1, A., Bu\u0161ek, P., \u0160edo, A. & Konvalinka, J. Molecular recognition of fibroblast activation protein for diagnostic and therapeutic applications. Biochim. Biophys. Acta (BBA) - Proteins Proteom. 1868, 140409 (2020).","journal-title":"Biochim. Biophys. Acta (BBA) - Proteins Proteom."},{"key":"75493_CR49","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.tox.2008.06.013","volume":"254","author":"SL Friedman","year":"2008","unstructured":"Friedman, S. L. Hepatic fibrosis\u2014overview. Toxicology 254, 120\u2013129 (2008).","journal-title":"Toxicology"},{"key":"75493_CR50","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/BF01324802","volume":"430","author":"ML Hautekeete","year":"1997","unstructured":"Hautekeete, M. L. & Geerts, A. The Hepatic Stellate (Ito) cell: its role in human liver disease. Virchows Arch. 430, 195\u2013207 (1997).","journal-title":"Virchows Arch."},{"key":"75493_CR51","doi-asserted-by":"crossref","unstructured":"Lovgren, A. K. et al. \u0392-Arrestin deficiency protects against pulmonary fibrosis in mice and prevents fibroblast invasion of extracellular matrix. Sci. Transl. Med. 3 (2011).","DOI":"10.1126\/scitranslmed.3001564"},{"key":"75493_CR52","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.cmpb.2010.01.007","volume":"99","author":"Y Zhang","year":"2010","unstructured":"Zhang, Y., Huo, M., Zhou, J. & Xie, S. PKSolver: an add-in program for pharmacokinetic and pharmacodynamic data analysis in Microsoft Excel. Comput. Methods Prog. Biomed. 99, 306\u2013314 (2010).","journal-title":"Comput. Methods Prog. Biomed."},{"key":"75493_CR53","doi-asserted-by":"publisher","first-page":"3618","DOI":"10.1016\/j.apsb.2022.03.014","volume":"12","author":"F Wang","year":"2022","unstructured":"Wang, F. et al. Inhibition of ASCT2 induces hepatic stellate cell senescence with modified proinflammatory secretome through an IL-1\u0391\/NF-\u039aB feedback pathway to inhibit liver fibrosis. Acta Pharm. Sin. B. 12, 3618\u20133638 (2022).","journal-title":"Acta Pharm. Sin. B."},{"key":"75493_CR54","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2014.122","volume":"5","author":"H Wang","year":"2014","unstructured":"Wang, H. et al. Downregulation of FAP suppresses cell proliferation and metastasis through PTEN\/PI3K\/AKT and Ras-ERK signaling in oral squamous cell carcinoma. Cell Death Dis. 5, e1155 (2014).","journal-title":"Cell Death Dis."},{"key":"75493_CR55","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-023-03073-8","volume":"23","author":"K Jiang","year":"2023","unstructured":"Jiang, K., Xu, L., Ning, J. & Cheng, F. FAP promotes clear cell renal cell carcinoma progression via activating the PI3K\/AKT\/MTOR signaling pathway. Cancer Cell Int 23, 217 (2023).","journal-title":"Cancer Cell Int"},{"key":"75493_CR56","doi-asserted-by":"publisher","first-page":"1389329","DOI":"10.3389\/fmed.2024.1389329","volume":"11","author":"E Shamsan","year":"2024","unstructured":"Shamsan, E. et al. The role of PI3K\/AKT signaling pathway in attenuating liver fibrosis: a comprehensive review. Front. Med. 11, 1389329 (2024).","journal-title":"Front. Med."},{"key":"75493_CR57","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1002\/jcc.22885","volume":"33","author":"T Lu","year":"2012","unstructured":"Lu, T. & Chen, F. Multiwfn: a multifunctional wavefunction analyzer. J. Comput. Chem. 33, 580\u2013592 (2012).","journal-title":"J. Comput. Chem."},{"key":"75493_CR58","doi-asserted-by":"publisher","first-page":"82503","DOI":"10.1063\/5.0216272","volume":"161","author":"T Lu","year":"2024","unstructured":"Lu, T. A comprehensive electron wavefunction analysis toolbox for chemists, Multiwfn. J. Chem. Phys. 161, 82503 (2024).","journal-title":"J. Chem. Phys."},{"key":"75493_CR59","doi-asserted-by":"publisher","first-page":"20323","DOI":"10.1039\/D1CP02805G","volume":"23","author":"J Zhang","year":"2021","unstructured":"Zhang, J. & Lu, T. Efficient evaluation of electrostatic potential with computerized optimized code. Phys. Chem. Chem. Phys. 23, 20323\u201320328 (2021).","journal-title":"Phys. Chem. Chem. Phys."},{"key":"75493_CR60","doi-asserted-by":"publisher","first-page":"W530","DOI":"10.1093\/nar\/gkab294","volume":"49","author":"MF Adasme","year":"2021","unstructured":"Adasme, M. F. et al. PLIP 2021: expanding the scope of the protein\u2013ligand interaction profiler to DNA and RNA. Nucleic Acids Res. 49, W530\u2013W534 (2021).","journal-title":"Nucleic Acids Res."},{"key":"75493_CR61","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1038\/nprot.2015.017","volume":"10","author":"I Mederacke","year":"2015","unstructured":"Mederacke, I., Dapito, D. H., Aff\u00f2, S., Uchinami, H. & Schwabe, R. F. High-yield and high-purity isolation of hepatic stellate cells from normal and fibrotic mouse livers. Nat. Protoc. 10, 305\u2013315 (2015).","journal-title":"Nat. Protoc."},{"key":"75493_CR62","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.1007\/s00204-022-03265-7","volume":"96","author":"E Zahmatkesh","year":"2022","unstructured":"Zahmatkesh, E. et al. In vitro modeling of liver fibrosis in 3D microtissues using scalable micropatterning system. Arch. Toxicol. 96, 1799\u20131813 (2022).","journal-title":"Arch. Toxicol."},{"key":"75493_CR63","doi-asserted-by":"publisher","first-page":"101423","DOI":"10.1016\/j.xpro.2022.101423","volume":"3","author":"L Peng","year":"2022","unstructured":"Peng, L., Jiang, J., Zhou, L., Nice, E. C. & Huang, C. A cellular thermal shift assay for detecting amino acid sites involved in drug target engagement. STAR Protoc. 3, 101423 (2022).","journal-title":"STAR Protoc."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-75493-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-75493-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-75493-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T01:19:12Z","timestamp":1787015952000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-75493-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,11]]},"references-count":63,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["75493"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-75493-9","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,11]]},"assertion":[{"value":"4 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"8545"}}